Hydrocortisone valerate. Double-blind comparison with two other topical steroids

Area of Science:

• Dermatology
• Pharmacology

Background:

• Atopic dermatitis is a common inflammatory skin condition.
• Topical corticosteroids are a mainstay treatment for atopic dermatitis.
• Development of effective and safe topical steroids is ongoing.

Purpose of the Study:

• To evaluate the efficacy and safety of hydrocortisone valerate cream (0.2%) in patients with atopic dermatitis.
• To compare hydrocortisone valerate cream (0.2%) against a fluorinated corticosteroid, a non-fluorinated corticosteroid, and a placebo.

Main Methods:

• Three double-blind, paired comparison clinical trials were conducted.
• Sixty-eight patients with atopic dermatitis participated.
• Medications were applied three times daily for up to four weeks or until disease clearance.

Main Results:

• Hydrocortisone valerate cream (0.2%) demonstrated efficacy comparable to beta-methasone valerate cream (0.1%).
• Hydrocortisone valerate cream (0.2%) was significantly more effective than hydrocortisone cream (0.1%) and placebo.
• No specific adverse events were detailed in the abstract.

Conclusions:

• Hydrocortisone valerate cream (0.2%) is an effective nonfluorinated topical corticosteroid for treating atopic dermatitis.
• It offers a viable alternative to fluorinated corticosteroids.
• Further studies may be warranted to assess long-term safety and efficacy.